Brief: Evelo Biosciences Says Co And Abdul Latif Jameel Health Entered Strategic Collaboration
23/03/2021 11:53
March 23 (Reuters) - Evelo Biosciences Inc EVLO.O :
* CO AND ABDUL LATIF JAMEEL HEALTH ENTERED INTO A STRATEGIC
COLLABORATION
* EVELO BIOSCIENCES-STRATEGIC COLLABORATION TO DEVELOP AND
COMMERCIALIZE CO'S LEAD INFLAMMATION PRODUCT CANDIDATE EDP1815
IN MIDDLE EAST, TURKEY, AFRICA
Source text for Eikon: ID:nGNX9Q28D
Further company coverage: EVLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evelo Biosciences
See all newsU.S. RESEARCH ROUNDUP- Evelo Biosciences, Nkarta, O'Reilly Automotive
U.S. STOCKS ON THE MOVE-DXC Technology, Nvidia, Lisata Therapeutics
Evelo Bio slumps after skin disease drug fails in mid-stage study
U.S. STOCKS ON THE MOVE-Nvidia, Westlake, North American steel companies
U.S. STOCKS ON THE MOVE-TMC, PayPal, TOMI